Label-free electrochemical immunosensor based on flower-like Ag/MoS2/rGO nanocomposites for ultrasensitive detection of carcinoembryonic antigen

[Display omitted] •A novel label-free electrochemical immunosensor was designed for detecting CEA.•Flower-like Ag/MoS2/rGO were employed as the signal amplification platform.•Ag/MoS2/rGO nanocomposites have a high electrocatalytic activity towards H2O2.•The immunosensor exhibited a high sensitivity...

Full description

Saved in:
Bibliographic Details
Published inSensors and actuators. B, Chemical Vol. 255; pp. 125 - 132
Main Authors Wang, Yaoguang, Wang, Yulan, Wu, Dan, Ma, Hongmin, Zhang, Yong, Fan, Dawei, Pang, Xuehui, Du, Bin, Wei, Qin
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •A novel label-free electrochemical immunosensor was designed for detecting CEA.•Flower-like Ag/MoS2/rGO were employed as the signal amplification platform.•Ag/MoS2/rGO nanocomposites have a high electrocatalytic activity towards H2O2.•The immunosensor exhibited a high sensitivity and a low detection limit. In this work, a label-free electrochemical immunosensor was developed for the quantitative detection of carcinoembryonic antigen (CEA). Flower-like Ag/MoS2/rGO nanocomposites were employed as the signal amplification platform of the designed immunosensor for the first time. Due to the synergistic effect between molybdenum disulfide (MoS2), reduced graphene oxide (rGO) and Ag nanoparticles (NPs), Ag/MoS2/rGO nanocomposites could provide a high sensitivity for the label-free electrochemical immunosensor. The detection mechanism was based on the monitoring of the electrocatalytic current response change towards the reduction of hydrogen peroxide (H2O2) when immunoreaction occurred on the surface of the electrode modified with Ag/MoS2/rGO nanocomposites. Using amperometric i-t curve to record the electrocatalytic process, the proposed immunosensor achieved an ultrasensitive and specific detection of CEA with a low detection limit of 1.6 fg/mL. Under optimal conditions, the fabricated immunosensor exhibited acceptable reproducibility, selectivity and excellent stability. This designed immunosensor could provide an effective method in the clinical diagnosis of other tumor markers.
ISSN:0925-4005
1873-3077
DOI:10.1016/j.snb.2017.07.129